263 related articles for article (PubMed ID: 24708583)
1. Effects of the dose-volume relationship on and risk factors for maxillary osteoradionecrosis after carbon ion radiotherapy.
Sasahara G; Koto M; Ikawa H; Hasegawa A; Takagi R; Okamoto Y; Kamada T
Radiat Oncol; 2014 Apr; 9(1):92. PubMed ID: 24708583
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and dosimetric evaluation of carbon ion radiation-induced osteoradionecrosis of mandible in head and neck tumors.
Musha A; Shimada H; Kubo N; Kawamura H; Okano N; Sato H; Kaminuma T; Okada K; Anakura M; Adachi A; Shirai K; Saitoh JI; Yokoo S; Chikamatsu K; Ohno T
Radiother Oncol; 2021 Aug; 161():205-210. PubMed ID: 34147522
[TBL] [Abstract][Full Text] [Related]
3. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations.
Aarup-Kristensen S; Hansen CR; Forner L; Brink C; Eriksen JG; Johansen J
Acta Oncol; 2019 Oct; 58(10):1373-1377. PubMed ID: 31364903
[No Abstract] [Full Text] [Related]
4. Osteoradionecrosis following treatment for head and neck cancer and the effect of radiotherapy dosimetry: the Guy's and St Thomas' Head and Neck Cancer Unit experience.
De Felice F; Thomas C; Patel V; Connor S; Michaelidou A; Sproat C; Kwok J; Burke M; Reilly D; McGurk M; Simo R; Lyons A; Oakley R; Jeannon JP; Lei M; Urbano TG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jul; 122(1):28-34. PubMed ID: 27039003
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric parameters predictive of nasolacrimal duct obstruction after carbon-ion radiotherapy for head and neck carcinoma.
Kubo N; Kubota Y; Kawamura H; Oike T; Sakai M; Kumazawa T; Miyasaka Y; Okazaki S; Kobayashi D; Sato H; Mizukami T; Musha A; Shirai K; Saitoh JI; Yokoo S; Chikamatsu K; Ohno T; Nakano T
Radiother Oncol; 2019 Dec; 141():72-77. PubMed ID: 31439449
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy.
Vischioni B; Russo S; Meuli M; Bonora M; Ronchi S; Ingargiola R; Camarda AM; Imparato S; Preda L; Ciocca M; Molinelli S; Orlandi E
Front Oncol; 2022; 12():829502. PubMed ID: 35311095
[TBL] [Abstract][Full Text] [Related]
7. Frequency of osteoradionecrosis of the lower jaw after radiotherapy of oral cancer patients correlated with dosimetric parameters and other risk factors.
Lang K; Held T; Meixner E; Tonndorf-Martini E; Ristow O; Moratin J; Bougatf N; Freudlsperger C; Debus J; Adeberg S
Head Face Med; 2022 Feb; 18(1):7. PubMed ID: 35219324
[TBL] [Abstract][Full Text] [Related]
8. Potential risk factors for jaw osteoradionecrosis after radiotherapy for head and neck cancer.
Kuhnt T; Stang A; Wienke A; Vordermark D; Schweyen R; Hey J
Radiat Oncol; 2016 Jul; 11():101. PubMed ID: 27473433
[TBL] [Abstract][Full Text] [Related]
9. Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions.
Ben-David MA; Diamante M; Radawski JD; Vineberg KA; Stroup C; Murdoch-Kinch CA; Zwetchkenbaum SR; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):396-402. PubMed ID: 17321069
[TBL] [Abstract][Full Text] [Related]
10. Extra-mandibular Osteoradionecrosis after the Treatment of Head and Neck Cancer.
Kovarik PDE; Patil R; Cvek J; Kelly C; Jackson M; Mackenzie L; West N; Willis N; Kovarik JP; Banks R; Kennedy M; Adams J; Iqbal MS
Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e498-e505. PubMed ID: 37433701
[TBL] [Abstract][Full Text] [Related]
11. Normal Tissue Complication Probability (NTCP) Prediction Model for Osteoradionecrosis of the Mandible in Patients With Head and Neck Cancer After Radiation Therapy: Large-Scale Observational Cohort.
van Dijk LV; Abusaif AA; Rigert J; Naser MA; Hutcheson KA; Lai SY; Fuller CD; Mohamed ASR;
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):549-558. PubMed ID: 33965514
[TBL] [Abstract][Full Text] [Related]
12. Dose constraints in the rectum and bladder following carbon-ion radiotherapy for uterus carcinoma: a retrospective pooled analysis.
Okonogi N; Fukahori M; Wakatsuki M; Ohkubo Y; Kato S; Miyasaka Y; Tsuji H; Nakano T; Kamada T
Radiat Oncol; 2018 Jun; 13(1):119. PubMed ID: 29941040
[TBL] [Abstract][Full Text] [Related]
13. Cause and occurrence timing of osteoradionecrosis of the jaw: a retrospective study focusing on prophylactic tooth extraction.
Wanifuchi S; Akashi M; Ejima Y; Shinomiya H; Minamikawa T; Furudoi S; Otsuki N; Sasaki R; Nibu KI; Komori T
Oral Maxillofac Surg; 2016 Dec; 20(4):337-342. PubMed ID: 27401528
[TBL] [Abstract][Full Text] [Related]
14. Patient and treatment-related risk factors for osteoradionecrosis of the jaw in patients with head and neck cancer.
Raguse JD; Hossamo J; Tinhofer I; Hoffmeister B; Budach V; Jamil B; Jöhrens K; Thieme N; Doll C; Nahles S; Hartwig ST; Stromberger C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Mar; 121(3):215-21.e1. PubMed ID: 26703417
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for brain injury after carbon ion radiotherapy for skull base tumors.
Koto M; Hasegawa A; Takagi R; Fujikawa A; Morikawa T; Kishimoto R; Jingu K; Tsujii H; Kamada T
Radiother Oncol; 2014 Apr; 111(1):25-9. PubMed ID: 24332023
[TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with the development of osteoradionecrosis (ORN) in Head and Neck cancer patients in Ireland: A 10-year retrospective review.
Fitzgerald KT; Lyons C; England A; McEntee MF; Devine A; O'Donovan T; O'Sullivan E
Radiother Oncol; 2024 Jul; 196():110286. PubMed ID: 38641259
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.
Kubota H; Miyawaki D; Mukumoto N; Ishihara T; Matsumura M; Hasegawa T; Akashi M; Kiyota N; Shinomiya H; Teshima M; Nibu KI; Sasaki R
Radiat Oncol; 2021 Jan; 16(1):1. PubMed ID: 33402192
[TBL] [Abstract][Full Text] [Related]
18. Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
Caparrotti F; Huang SH; Lu L; Bratman SV; Ringash J; Bayley A; Cho J; Giuliani M; Kim J; Waldron J; Hansen A; Tong L; Xu W; O'Sullivan B; Wood R; Goldstein D; Hope A
Cancer; 2017 Oct; 123(19):3691-3700. PubMed ID: 28608925
[TBL] [Abstract][Full Text] [Related]
19. Is Dose Volume a Better Predictor of Osteoradionecrosis Risk Than Total Dose for Patients Who Have Received Head and Neck Radiation?
DeLuke D; Carrico C; Ray C; Stilianoudakis S; Holler S; Padilla L; Song S
J Oral Maxillofac Surg; 2022 Sep; 80(9):1557-1563. PubMed ID: 35594907
[TBL] [Abstract][Full Text] [Related]
20. Relationship between oral health status and development of osteoradionecrosis of the mandible: a retrospective longitudinal study.
Katsura K; Sasai K; Sato K; Saito M; Hoshina H; Hayashi T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jun; 105(6):731-8. PubMed ID: 18329913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
